(2024). Delineating excess comorbidities in idiopathic pulmonary fibrosis: an observational study. Respir Res, 25, 249. http://doi.org/10.1186/s12931-024-02875-2
. Cohort Studies
(2024). Assessing the uptake of incentivised physical health checks for people with serious mental illness: a cohort study in primary care. Br J Gen Pract, 74, e449-e455. http://doi.org/10.3399/bjgp.2023.0532
. (2024). Incidence, prevalence and mortality of idiopathic pulmonary fibrosis in England from 2008 to 2018: a cohort study. Thorax, 79, 624-631. http://doi.org/10.1136/thorax-2023-220887
. (2024). Associations between prior healthcare use, time to diagnosis, and clinical outcomes in inflammatory bowel disease: a nationally representative population-based cohort study. Bmj Open Gastroenterol, 11. http://doi.org/10.1136/bmjgast-2024-001371
. (2024). Risk of bleeding amongst warfarin and direct oral anticoagulant users prescribed immediate antibiotics for respiratory tract infection: Cohort study. Pharmacoepidemiol Drug Saf, 33, e5794. http://doi.org/10.1002/pds.5794
. (2024). Trends of use and characterisation of anti-dementia drugs users: a large multinational-network population-based study. Age Ageing, 53. http://doi.org/10.1093/ageing/afae106
. (2024). Risk factors for asthma-related hospital and intensive care admissions in children, adolescents and adults: a cohort study using primary and secondary care data. Bmj Open Respir Res, 11. http://doi.org/10.1136/bmjresp-2023-001746
. (2024). Multiple adverse outcomes associated with antipsychotic use in people with dementia: population based matched cohort study. Bmj, 385, e076268. http://doi.org/10.1136/bmj-2023-076268
. (2024). Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study. Bmj, 385, e078242. http://doi.org/10.1136/bmj-2023-078242
. (2024). The effectiveness of COVID-19 vaccines to prevent long COVID symptoms: staggered cohort study of data from the UK, Spain, and Estonia. Lancet Respir Med, 12, 225-236. http://doi.org/10.1016/s2213-2600(23)00414-9
.